Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those ...

Novo Nordisk's drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC's ...

Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early ...

Wegovy can help people with excess weight and obesity lose weight and improve their health. And you don’t need to drive to a ...

The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an ...

Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 ...

While most side effects are likely to disappear when the medication is stopped, any damage to the teeth is permanent ...

New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...

Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...